
ABOUT PERKINELMER, INC.
PerkinElmer’s advanced analytics and services solutions for Clinical Development help the world’s leading biopharmaceutical, medical device and diagnostics manufactures discover new therapeutics faster by streamlining clinical operations, transforming risk into safety and enabling actionable decisions that can lead to better health outcomes.
CONTACT INFORMATION
PerkinElmer Informatics, Inc
940 Winter St
Waltham, MA 02451
UNITED STATES
Phone: 203 925-4602
BROCHURES
FEATURED ARTICLES
-
To achieve drug approval, trials must collect, combine, and analyze diverse data sets that support operational, safety review, risk management, and other analyses crucial to development.
-
Clinical trials can expose both predicted and unexpected safety signals. Surveillance must therefore look beyond expected adverse events to detect possible safety signals.
-
Create a system based on connectivity and automation, aggregated and usable data, flexible analysis, and methods of collaborative data review by centralizing analysis and communications.
-
In a recent webinar, experts from PerkinElmer Informatics explored how solutions like its TIBCO Spotfire platform enable better, more streamlined clinical studies.
-
For medical monitors, the problem with off-the-shelf analytics tools is the lack of tailoring for medical review needs. The right data visualization tool can help medical monitors to tailor and improve their data review processes and enhance their ability to identify safety signals both quickly and surely.
-
A pharmaceutical company first was looking to deploy a software solution for a small group of R&D users for analyzing research data. Read how the TIBCO Spotfire®, an enterprise-class visualization and analytics platform, allowed them to exploit an array of functionality, from chemical structure analysis to statistical modeling, to build dashboards and visualizations that maximize understanding of R&D data.
-
This article examines data challenges faced by sponsors and the underlying problems driving those challenges. It also details fast and flexible new processes and solutions designed to help overcome these challenges by serving sponsors’ ever-increasing need to analyze complex data.
-
Watch how Signals Line Listing Review enables clinical study teams to review, query, and track the status of their line listings in a collaborative, centralized, and scalable environment.
-
A Top 10 global biopharmaceutical company needed to implement a single clinical study data review system to reduce the time, cost, and risk of running their clinical trials while accelerating the time to market. The company deployed PerkinElmer's interactive data visualization and analysis solution, which is quickly becoming the tool of choice for clinicians and safety reviewers.
-
Look at some of the main challenges of clinical data review and discuss effective strategies to address these, before explaining how our solutions can be deployed to bring urgently needed therapeutics to patients faster.
-
Master how a single, integrated data analytics and visualization platform, supported by an experienced partner, can help you move your investigational product to market more quickly.
-
Reasoning for physician monitors’ reluctance, and what technology needs to offer to convince monitors their work can be more efficient: quickly detecting safety signals and speeding time to submission.
-
Learn about the challenges for Sponsors and CROs when integrating a vast array of data sources, typical relational database structures and why they don’t work for clinical analytics, as well as the ideal clinical data aggregation solutions for continuous, automatic data consolidation.
-
To enable the completion of clinical trials as safely, efficiently and quickly as possible, PerkinElmer Informatics’ clinical solutions streamline clinical trial data visualization and analysis with real-time access to clinical data in all phases of clinical development.
-
How to identify, hire, and empower a modern medical monitor to help your next study proceed toward submission more productively, and with greater data integrity, than ever before.
-
How a $23 billion publicly-held global specialty pharmaceutical company leveraged a software application to strike balance among its clinical studies portfolio, resources, and budget.
-
Exploratory data analysis is performed at different levels in the Novartis research and development environment. By implementing a solution that creates a workflow for exploratory clinical safety data analysis, they have access to interactive graphical data exploration that provides an efficient, powerful, and flexible tool to improve both detection and systematic assessment of safety signals.
-
Overcoming the many known barriers to adopting and implementing an RBM program.
-
What to consider when making this important strategic decision.
-
What is the medical monitor's role in the latest ICH E6 (r2) guidance and how to get them to adopt technology that will help them experience tangible efficiency and quality gains.